Director - Commercial Launch Logistics Management US
BioNTech
Summary
As the Commercial Logistics Lead for US Distribution, you will play a pivotal role in ensuring BioNTech's successful market entry and commercialization efforts in the United States. Reporting to the Director of Regional Logistics Operations US, you will lead the development and operational readiness of our logistics and distribution network. Your work will directly contribute to ensuring seamless product launches, compliance with regulatory standards, and alignment with BioNTech's mission to improve global health through innovative therapies.
Job description
About the Role
As the Commercial Logistics Lead for US Distribution, you will play a pivotal role in ensuring BioNTech's successful market entry and commercialization efforts in the United States. Reporting to the Director of Regional Logistics Operations US, you will lead the development and operational readiness of our logistics and distribution network. Your work will directly contribute to ensuring seamless product launches, compliance with regulatory standards, and alignment with BioNTech's mission to improve global health through innovative therapies.
Your Contribution
- Drive the end-to-end implementation and operational readiness of the US distribution network, including onboarding and managing specialty distributors and logistics partners
- Act as the primary logistics interface for the US Commercial organization, aligning commercial strategies with operational execution
- Lead the setup and integration of Lead-to-Cash (L2C) processes, ensuring smooth order fulfillment, invoicing flows, and data integration
- Establish logistics processes, SOPs, and governance structures required for US market entry and commercialization
- Oversee regulatory compliance across all US states, including acting as (or managing) the Designated Representative for state licenses under DSCSA regulations
- Manage operational implementation of warehouse and transportation setups to ensure GDP compliance and scalability
A Good Match
- Bachelor's degree, 8 plus years in pharmaceutical or biotech logistics, distribution, or supply chain operations within the US market
- Proven expertise in setting up or scaling distribution networks involving 3PLs, specialty distributors, group purchasing organizations, or wholesale channels
- Strong understanding of US state licensing requirements and experience as a Designated Representative (License Holder)
- Hands-on experience with Lead-to-Cash (L2C) processes, system integrations (e.g., ERP, EDI), and commercial launch readiness
- Solid knowledge of GDP requirements, warehousing operations in regulated environments, and specialty distribution networks
- Entrepreneurial mindset with demonstrated project leadership skills across complex implementations involving multiple stakeholders
Requirements
- Bachelor's degree
- 8 plus years in pharmaceutical or biotech logistics, distribution, or supply chain operations within the US market
- Proven expertise in setting up or scaling distribution networks involving 3PLs, specialty distributors, group purchasing organizations, or wholesale channels
- Strong understanding of US state licensing requirements and experience as a Designated Representative (License Holder)
- Hands-on experience with Lead-to-Cash (L2C) processes, system integrations (e.g., ERP, EDI), and commercial launch readiness
- Solid knowledge of GDP requirements, warehousing operations in regulated environments, and specialty distribution networks
- Entrepreneurial mindset with demonstrated project leadership skills across complex implementations involving multiple stakeholders
Benefits
- Health Insurance
- Annual Bonus
- Equity
Company overview
BioNTech SE is a pioneering German multinational biotechnology company headquartered in Mainz, Germany, that specializes in developing innovative immunotherapies and vaccines for cancer and infectious diseases. Founded in 2008 by scientists Uğur Şahin, Özlem Türeci, and Christoph Huber, the company gained global recognition for co-developing the first approved mRNA-based COVID-19 vaccine with Pfizer. BioNTech's core expertise lies in mRNA technology, which it has been researching for over 15 years, with applications spanning individualized cancer medicine, infectious disease prevention, and novel therapeutic approaches. The company operates a diversified portfolio including mRNA cancer immunotherapies, next-generation immunomodulators, targeted therapies, and antibody-drug conjugates. With approximately 6,800 employees across more than 20 global sites, BioNTech maintains a strong focus on oncology, advancing multiple late-stage clinical programs while expanding its infectious disease pipeline to address conditions like malaria, tuberculosis, and mpox. The company's strategic acquisitions, including InstaDeep for AI capabilities and CureVac for mRNA expertise, further strengthen its position as a leader in next-generation biopharmaceutical innovation.